Breaking News

LSNE Acquires PSC Biotech’s Parenteral Mfg. Facility

Expands aseptic fill finish capabilities

Author Image

By: Kristin Brooks

Managing Editor, Contract Pharma

Lyophilization Services of New England (LSNE) has acquired PSC Biotech’s 37,000 sq.-ft. cGMP aseptic fill finish manufacturing facility in Madison, WI. This acquisition expands LSNE’s manufacturing capabilities, adds new service offerings and allows the company to accommodate its customers’ project timing requirements. The new facility will be called LSNE-Madison. Financial terms were not disclosed. LSNE anticipates full manufacturing activities to begin later this year, following a short period...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters